| ADR Ontology |
| ADR Term |
Mucoepidermoid carcinoma |
| ADR ID |
BADD_A10446 |
| ADR Hierarchy |
|
| Description |
A tumor of both low- and high-grade malignancy. The low-grade grow slowly, appear in any age group, and are readily cured by excision. The high-grade behave aggressively, widely infiltrate the salivary gland and produce lymph node and distant metastases. Mucoepidermoid carcinomas account for about 21% of the malignant tumors of the parotid gland and 10% of the sublingual gland. They are the most common malignant tumor of the parotid. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p575; Holland et al., Cancer Medicine, 3d ed, p1240) [MeSH] |
| MedDRA Code |
10057269 |
| MeSH ID |
D018277
|
|
ADR Severity Grade (FAERS)
|
|
|
ADR Severity Grade (CTCAE)
|
Not Available
|
| Synonym |
| Mucoepidermoid carcinoma | Carcinoma, Mucoepidermoid | Carcinomas, Mucoepidermoid | Mucoepidermoid Carcinoma | Mucoepidermoid Carcinomas |
|
|
| Drugs Leading to the ADR |
| Drug ID | Drug Name | ADR Frequency (FAERS) | ADR Severity Grade (FAERS) | | BADD_D02464 | Fingolimod | 0.000241% | |
| The 1th Page 1
Total 1 Pages
|
|
